Welcome to our dedicated page for SOLSTICE ADVANCED MATLS SEC filings (Ticker: SOLS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Solstice Advanced Materials Inc. filings document the public-company record of a high-performance specialty materials issuer, including earnings releases furnished on Form 8-K, quarterly cash dividend declarations on common stock, and business disclosures tied to refrigerants, electronic materials and nuclear services.
The company’s proxy and governance filings cover shareowner proposal and director-nomination procedures, annual-meeting voting matters, and executive compensation. Other current reports describe restricted stock units and performance stock units granted under the 2025 Stock Incentive Plan, including equity-settled award terms linked to common stock and performance measures.
Clifford Jason Michael reported acquisition or exercise transactions in this Form 4 filing.
Solstice Advanced Materials Inc. SVP and Chief HR Officer Clifford Jason Michael reported an equity award of 4,625 restricted stock units on February 24, 2026 at a stated price of $0.00 per unit. Each RSU represents a contingent right to receive one share of Solstice common stock.
The new RSUs will vest 33% on February 24, 2027, 33% on February 24, 2028, and 34% on February 24, 2029, subject to continued employment. Additional RSU awards are scheduled to vest in equal installments on October 30, 2028 and October 30, 2029, and in amounts of 11,590, 11,589, and 5,795 units on June 2, 2026, June 2, 2027, and June 2, 2028, respectively, also subject to continued employment. Following these awards, he also directly holds 1,645 shares of common stock.
Solstice Advanced Materials Inc. reported that Chief Accounting Officer John S. Barresi acquired 3,558 restricted stock units (RSUs) on February 24, 2026 as a grant at a stated price of $0.00 per unit. Each RSU represents a contingent right to receive one share of Solstice common stock.
After this award and related updates, Barresi directly holds 24,525 RSUs. The newly granted RSUs vest 33% on each of February 24, 2027 and February 24, 2028, and 34% on February 24, 2029, subject to continued employment. Previously granted RSUs are scheduled to vest 8,584 on June 16, 2026, 8,584 on June 16, 2027, and 7,357 on June 16, 2028, also subject to continued employment.
Solstice Advanced Materials Inc. approved new long-term equity awards for senior executives, combining time-based restricted stock units (RSUs) and performance stock units (PSUs) under its 2025 Stock Incentive Plan. Each unit gives the right to one share of common stock if vesting conditions are met.
On February 24, 2026, CEO David Sewell received 46,244 RSUs and 46,244 target PSUs. Other named officers received smaller but similar grants, including the CFO with 9,961 RSUs and 9,961 target PSUs. RSUs vest in three equal annual installments.
PSUs vest after a three-year performance period covering fiscal years 2026 through 2028, based on adjusted earnings per share and return on invested capital, with a modifier tied to relative total shareholder return and continued employment.
Solstice Advanced Materials Inc. set the date of its 2026 Annual Meeting of Shareowners for Friday, May 22, 2026. Shareowners of record at the close of business on Monday, March 23, 2026 will be entitled to receive notice of and vote at the meeting.
Shareowner proposals for inclusion in the proxy materials under Rule 14a-8 must arrive at the company’s New Jersey headquarters by Thursday, March 5, 2026 and meet all Rule 14a-8 requirements. Proposals or director nominations outside Rule 14a-8 had to follow the company’s By-Laws, with earlier advance notice windows already specified.
Under the company’s proxy access By-Laws, requests to include shareowner-nominated directors in the 2026 proxy materials must be received by March 2, 2026. Shareowners intending to solicit proxies for their own director nominees must also provide the information required by Rule 14a-19 no later than March 23, 2026.
Solstice Advanced Materials Inc. reports its first full year as an independent advanced materials company following its October 30, 2025 spin-off from Honeywell. The company now trades on Nasdaq under “SOLS” and operates through two segments: Refrigerants & Applied Solutions (RAS) and Electronic & Specialty Materials (ESM).
RAS focuses on low global warming potential refrigerants, blowing agents, solvents, aerosols, nuclear conversion services and healthcare packaging, sold under brands such as Solstice, Genetron and Aclar. ESM supplies semiconductor materials, high-strength fibers and life sciences chemicals through brands including Spectra, Fluka and Hydranal.
Solstice highlights global scale with about 3,000 customers in roughly 120 countries, 20 manufacturing sites, four R&D centers and approximately 4,100 employees as of December 31, 2025. Its portfolio is supported by more than 5,700 issued patents and pending applications and a stated focus on secular growth themes such as sustainability, semiconductors, healthcare, defense and electrification. The company also reports a roughly $2.2 billion backlog in its nuclear conversion joint venture and notes capital expenditures equal to 10% of net sales in 2025 to expand capacity for expected long-term demand.
Solstice Advanced Materials Inc. reported mixed 2025 results with solid sales growth but sharply lower earnings, initiated a quarterly dividend, and issued 2026 guidance. Fourth-quarter 2025 net sales were $987 million, up 8% year over year, driven by double-digit growth in Refrigerants, Nuclear (Alternative Energy Services), and Electronic Materials. However, Q4 net income attributable to Solstice fell to $41 million from $133 million, and Adjusted Standalone EBITDA declined to $189 million, with margin compressing to 19.1% due mainly to higher costs, refrigerant mix shifts, and plant downtime.
For full-year 2025, net sales reached $3.886 billion, up 3%, while net income attributable to Solstice dropped to $237 million from $594 million, reflecting higher income tax expense tied to the spin-off and softer margins. Full-year Adjusted Standalone EBITDA was $957 million, down 4%, with a 24.6% margin. Capital expenditures rose 38% to $408 million to support long-term growth, and net leverage stood at about 1.5x based on 2025 Adjusted Standalone EBITDA. The Board declared the company’s first quarterly dividend of $0.075 per share, payable March 10, 2026 to shareowners of record on February 24, 2026. For 2026, Solstice guided to net sales of $3.9–$4.1 billion, Adjusted EBITDA of $975–$1,025 million, and Adjusted Diluted EPS of $2.45–$2.75, alongside capital spending of $400–$425 million.
The Vanguard Group has filed an amended Schedule 13G reporting beneficial ownership of 18,386,879 shares of Solstice Advanced Materials Inc. common stock, representing 11.58% of the outstanding class. Vanguard reports no sole voting or dispositive power, with shared voting power over 1,403,379 shares and shared dispositive power over all 18,386,879 shares.
The filing notes an internal realignment effective January 12, 2026, after which certain Vanguard subsidiaries or business divisions are expected to report beneficial ownership separately on a disaggregated basis. Vanguard states the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of Solstice Advanced Materials.
BlackRock, Inc. has filed a Schedule 13G reporting a significant institutional stake in Solstice Advanced Materials Inc. common stock as of 12/31/2025. BlackRock reports beneficial ownership of 16,505,376 Solstice shares, representing 10.4% of the outstanding common stock. It has sole voting power over 16,097,392 shares and sole dispositive power over all 16,505,376 shares, with no shared voting or dispositive authority.
The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Solstice. One BlackRock-affiliated fund, iShares Core S&P Small-Cap ETF, holds an interest in Solstice common stock that is itself more than five percent of the total outstanding shares.
BlackRock, Inc. has filed a Schedule 13G reporting a significant institutional stake in Solstice Advanced Materials Inc. common stock as of 12/31/2025. BlackRock reports beneficial ownership of 16,505,376 Solstice shares, representing 10.4% of the outstanding common stock. It has sole voting power over 16,097,392 shares and sole dispositive power over all 16,505,376 shares, with no shared voting or dispositive authority.
The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Solstice. One BlackRock-affiliated fund, iShares Core S&P Small-Cap ETF, holds an interest in Solstice common stock that is itself more than five percent of the total outstanding shares.